Shahid Mallick MD in Sugar Land, Texas

Medical School: Sorry, his university is not listed
Graduation Year: 1987
The Primary Medical Specialty for Shahid Mallick MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 37
PAC (PECOS ID)#: 9436116001
NPI #: 1396738415
NPI Created On: 08/24/2005
NPI Last Updated Listed as: 10/09/2007
Primary Taxonomy Code: 207RP1001X
License Number:
J8042
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Community Health Choice
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Urdu, Pakistani, Other, Hindi, Spanish.

Services and Procedures include:

1. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
2. Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen
3. Determination of lung volumes using plethysmography
4. Measurement of lung diffusing capacity
5. Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
6. New patient office or other outpatient visit, typically 45 minutes
7. Established patient office or other outpatient visit, typically 15 minutes
8. Established patient office or other outpatient, visit typically 25 minutes
9. Hospital observation care on day of discharge
10. Hospital observation care, typically 70 minutes
11. Initial hospital inpatient care, typically 50 minutes per day
12. Initial hospital inpatient care, typically 70 minutes per day
13. Subsequent observation care, typically 25 minutes per day
14. Subsequent hospital inpatient care, typically 15 minutes per day
15. Subsequent hospital inpatient care, typically 25 minutes per day
16. Hospital discharge day management, 30 minutes or less
17. Hospital discharge day management, more than 30 minutes
18. Critical care delivery critically ill or injured patient, first 30-74 minutes
19. Injection, methylprednisolone acetate, 20 mg